FunHoP analysis reveals upregulation of mitochondrial genes in prostate cancer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36282866.
- Also identified by DOI 10.1371/journal.pone.0275621 and PMC identifier 9595552.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mitochondrial activity in cancer cells has been central to cancer research since Otto Warburg first published his thesis on the topic in 1956. Although Warburg proposed that oxidative phosphorylation in the tricarboxylic acid (TCA) cycle was perturbed in cancer, later research has shown that oxidative phosphorylation is activated in most cancers, including prostate cancer (PCa). However, more detailed knowledge on mitochondrial metabolism and metabolic pathways in cancers is still lacking. In this study we expand our previously developed method for analyzing functional homologous proteins (FunHoP), which can provide a more detailed view of metabolic pathways. FunHoP uses results from differential expression analysis of RNA-Seq data to improve pathway analysis. By adding information on subcellular localization based on experimental data and computational predictions we can use FunHoP to differentiate between mitochondrial and non-mitochondrial processes in cancerous and normal prostate cell lines. Our results show that mitochondrial pathways are upregulated in PCa and that splitting metabolic pathways into mitochondrial and non-mitochondrial counterparts using FunHoP adds to the interpretation of the metabolic properties of PCa cells.
Medical subject headings
- Male
- Humans
- Up-Regulation
- Genes, Mitochondrial
- Cell Line, Tumor
- Oxidative Phosphorylation
- Prostatic Neoplasms
- Prostatic Neoplasms/genetics
- Prostatic Neoplasms/metabolism
- Tricarboxylic Acids